1. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10 (October 2021) Authors: Han, Joseph K; Bachert, Claus; Fokkens, Wytske; Desrosiers, Martin; Wagenmann, Martin; Lee, Stella E; Smith, Steven G; Martin, Neil; Mayer, Bhabita; Yancey, Steven W; Sousa, Ana R; Chan, Robert; Hopkins, Claire; Ahlström Emanuelsson, Cecilia; Ardusso, Ledit; Armstrong, Michael; Bardin, Philip; Ba... Journal: Lancet Issue: Volume 9:Issue 10(2021) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗